In the field of GI cancer, a promalignant role of the CXCL13/CXCR5 axis has been shown for pancreatic cancer and gastric cancer as well as hepatocellular carcinoma [15,23]. This evidence concerns the gene CXCR5 and hepatocellular carcinoma.